Efficacy against Covid-related illness averaged about 85% after a full course, increasing to nearly 100% protection from serious illness, hospitalization, or death, said Julia Shapiro, Natalie Dean, Ira Longini, and colleagues paper published on Friday before review and publication. Researchers from the University of Florida compared the data from the articles and media reports for products that have undergone double-blind, placebo-controlled late-stage vaccine trials as well as observational studies.
.
0 Comments